C Frank Bennett sold $7.1M of Ionis Pharmaceuticals (IONS)

Executed Feb 2, disclosed Feb 4, 2 days later.

Value, as filed

$7.1M

85,089 sh across 3 lots

Executed

Feb 2

the trade date, as filed

Disclosed

Feb 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CB C Frank Bennett EVP, Chief Scientific Officer profile →

C Frank Bennett (EVP, Chief Scientific Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $7.1M of IONS (85,089 sh across 3 lots, as filed), executed Feb 2.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by C Frank Bennett in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $1.7M
20,536 sh across 2 lots
Exec Jul 7
Filed Jul 9 · 7:26 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $6.7M
84,287 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $488K
5,885 sh × $82.95
Exec Jan 30
Filed Feb 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $675K
8,977 sh × $75.15
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $358K
6,000 sh × $59.60
Exec Sep 5 2025
Filed Sep 9 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $2.3M
38,909 sh across 2 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $440K
10,000 sh × $43.98
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $222K
6,752 sh × $32.90
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET